Chemoinformaics analysis of 1,2,4,5-Tetramethylbenzene
Molecular Weight | 134.222 | nRot | 0 |
Heavy Atom Molecular Weight | 120.11 | nRig | 6 |
Exact Molecular Weight | 134.11 | nRing | 1 |
Solubility: LogS | -4.226 | nHRing | 0 |
Solubility: LogP | 4.11 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 0 | APOL | 26.0351 |
nHD | 0 | BPOL | 14.0449 |
QED | 0.511 |
Synth | 1.302 |
Natural Product Likeliness | -0.444 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.079 |
Pgp-sub | 0.02 |
HIA | 0.008 |
CACO-2 | -4.631 |
MDCK | 0.0000195 |
BBB | 0.899 |
PPB | 0.922792 |
VDSS | 0.914 |
FU | 0.0603267 |
CYP1A2-inh | 0.762 |
CYP1A2-sub | 0.948 |
CYP2c19-inh | 0.603 |
CYP2c19-sub | 0.898 |
CYP2c9-inh | 0.13 |
CYP2c9-sub | 0.717 |
CYP2d6-inh | 0.302 |
CYP2d6-sub | 0.933 |
CYP3a4-inh | 0.11 |
CYP3a4-sub | 0.523 |
CL | 9.843 |
T12 | 0.429 |
hERG | 0.019 |
Ames | 0.221 |
ROA | 0.023 |
SkinSen | 0.249 |
Carcinogencity | 0.656 |
EI | 0.996 |
Respiratory | 0.036 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.913617 |